Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplastic Stem Cells | 3 | 2017 | 143 | 1.140 |
Why?
|
| Neuroblastoma | 3 | 2017 | 380 | 1.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2017 | 122 | 0.680 |
Why?
|
| Transcriptome | 4 | 2018 | 580 | 0.620 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2017 | 30 | 0.610 |
Why?
|
| Gene Expression Profiling | 5 | 2017 | 1388 | 0.600 |
Why?
|
| Sulfoxides | 1 | 2017 | 6 | 0.600 |
Why?
|
| Genes, myc | 1 | 2017 | 39 | 0.590 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2015 | 292 | 0.540 |
Why?
|
| Pyrimidines | 1 | 2017 | 367 | 0.480 |
Why?
|
| Porphobilinogen Synthase | 1 | 2012 | 4 | 0.440 |
Why?
|
| Genomics | 2 | 2017 | 720 | 0.440 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 297 | 0.430 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2012 | 96 | 0.420 |
Why?
|
| Immunotherapy | 2 | 2017 | 631 | 0.410 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 1200 | 0.410 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 183 | 0.400 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2015 | 763 | 0.390 |
Why?
|
| Hematologic Neoplasms | 1 | 2013 | 329 | 0.340 |
Why?
|
| Cell Line, Tumor | 5 | 2017 | 2433 | 0.310 |
Why?
|
| DNA-Binding Proteins | 2 | 2013 | 1214 | 0.310 |
Why?
|
| Risk | 3 | 2017 | 657 | 0.300 |
Why?
|
| Transcription Factors | 2 | 2013 | 1580 | 0.270 |
Why?
|
| Promoter Regions, Genetic | 4 | 2013 | 943 | 0.270 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 2360 | 0.260 |
Why?
|
| Prognosis | 3 | 2017 | 3639 | 0.230 |
Why?
|
| Gene Silencing | 2 | 2017 | 174 | 0.230 |
Why?
|
| Pituitary Hormones | 1 | 2002 | 7 | 0.220 |
Why?
|
| Adrenocortical Hyperfunction | 1 | 2002 | 6 | 0.220 |
Why?
|
| Cushing Syndrome | 1 | 2002 | 24 | 0.220 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2002 | 131 | 0.210 |
Why?
|
| Cardiomegaly | 2 | 2012 | 114 | 0.200 |
Why?
|
| Homeodomain Proteins | 2 | 2017 | 538 | 0.200 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2012 | 104 | 0.190 |
Why?
|
| Circadian Rhythm | 1 | 2002 | 294 | 0.180 |
Why?
|
| Child | 5 | 2017 | 6930 | 0.180 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2012 | 428 | 0.170 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 2904 | 0.170 |
Why?
|
| Histones | 2 | 2012 | 311 | 0.170 |
Why?
|
| Mice | 9 | 2013 | 11439 | 0.150 |
Why?
|
| Acute Chest Syndrome | 1 | 2017 | 16 | 0.150 |
Why?
|
| Embryonic Stem Cells | 1 | 2017 | 79 | 0.140 |
Why?
|
| Exosomes | 1 | 2017 | 50 | 0.140 |
Why?
|
| Humans | 17 | 2018 | 85796 | 0.140 |
Why?
|
| Pharmacogenomic Testing | 1 | 2017 | 97 | 0.140 |
Why?
|
| Recovery of Function | 1 | 2017 | 271 | 0.140 |
Why?
|
| Exons | 1 | 2017 | 452 | 0.130 |
Why?
|
| RNA Polymerase II | 2 | 2012 | 55 | 0.130 |
Why?
|
| Cell Proliferation | 3 | 2017 | 1598 | 0.130 |
Why?
|
| Animals | 10 | 2013 | 26652 | 0.130 |
Why?
|
| Protein Binding | 3 | 2013 | 1462 | 0.120 |
Why?
|
| Citric Acid | 1 | 2013 | 38 | 0.110 |
Why?
|
| Child, Preschool | 3 | 2017 | 3612 | 0.110 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2013 | 5 | 0.110 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2013 | 30 | 0.110 |
Why?
|
| Graft vs Leukemia Effect | 1 | 2013 | 11 | 0.110 |
Why?
|
| Adiponectin | 1 | 2013 | 23 | 0.110 |
Why?
|
| Infant | 3 | 2017 | 3051 | 0.110 |
Why?
|
| Cell Separation | 1 | 2013 | 196 | 0.110 |
Why?
|
| Nucleotide Motifs | 1 | 2013 | 47 | 0.110 |
Why?
|
| Oncogene Protein v-akt | 1 | 2012 | 21 | 0.110 |
Why?
|
| Burkitt Lymphoma | 1 | 2012 | 31 | 0.110 |
Why?
|
| Apoptosis | 2 | 2017 | 1690 | 0.110 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 72 | 0.110 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2012 | 28 | 0.110 |
Why?
|
| Heparin | 1 | 2013 | 175 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2012 | 79 | 0.110 |
Why?
|
| Sirtuins | 1 | 2012 | 45 | 0.110 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 135 | 0.110 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 113 | 0.110 |
Why?
|
| Diet, High-Fat | 1 | 2013 | 114 | 0.100 |
Why?
|
| Chromosome Deletion | 1 | 2012 | 229 | 0.100 |
Why?
|
| Allografts | 1 | 2013 | 174 | 0.100 |
Why?
|
| Eye | 1 | 2012 | 111 | 0.100 |
Why?
|
| Computational Biology | 1 | 2015 | 528 | 0.100 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 456 | 0.100 |
Why?
|
| Tamoxifen | 1 | 2012 | 168 | 0.100 |
Why?
|
| DNA Primers | 1 | 2012 | 545 | 0.100 |
Why?
|
| Metabolic Syndrome | 1 | 2013 | 126 | 0.100 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2013 | 153 | 0.100 |
Why?
|
| Leukemia, Myeloid | 1 | 2012 | 249 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 1379 | 0.100 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2011 | 67 | 0.100 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 32 | 0.100 |
Why?
|
| Signal Transduction | 4 | 2015 | 3264 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1471 | 0.100 |
Why?
|
| Cell Line | 2 | 2012 | 2474 | 0.100 |
Why?
|
| Software | 1 | 2015 | 653 | 0.100 |
Why?
|
| Autophagy | 1 | 2012 | 150 | 0.100 |
Why?
|
| Smad3 Protein | 1 | 2010 | 15 | 0.100 |
Why?
|
| Smad2 Protein | 1 | 2010 | 18 | 0.100 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 878 | 0.090 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2011 | 93 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 929 | 0.090 |
Why?
|
| Genome, Human | 1 | 2015 | 756 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 125 | 0.090 |
Why?
|
| Binding Sites | 1 | 2013 | 1104 | 0.090 |
Why?
|
| Anticoagulants | 1 | 2013 | 406 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 382 | 0.090 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 1202 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 324 | 0.090 |
Why?
|
| Recurrence | 1 | 2013 | 1136 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2012 | 405 | 0.090 |
Why?
|
| Transplantation Conditioning | 1 | 2011 | 373 | 0.090 |
Why?
|
| Protein Methyltransferases | 1 | 2009 | 14 | 0.090 |
Why?
|
| Graft vs Host Disease | 1 | 2011 | 365 | 0.090 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2009 | 57 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 1054 | 0.080 |
Why?
|
| Base Sequence | 1 | 2012 | 2334 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 302 | 0.080 |
Why?
|
| Disease Progression | 1 | 2013 | 1458 | 0.080 |
Why?
|
| Cell Membrane | 1 | 2011 | 666 | 0.080 |
Why?
|
| Acetylation | 3 | 2013 | 121 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 707 | 0.080 |
Why?
|
| Age Factors | 1 | 2013 | 1828 | 0.080 |
Why?
|
| Mutation | 2 | 2017 | 3978 | 0.080 |
Why?
|
| DNA Methylation | 2 | 2011 | 630 | 0.080 |
Why?
|
| Graft Survival | 1 | 2011 | 888 | 0.080 |
Why?
|
| Time Factors | 2 | 2013 | 5178 | 0.070 |
Why?
|
| Algorithms | 1 | 2015 | 1824 | 0.070 |
Why?
|
| Female | 8 | 2017 | 44218 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 1465 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2012 | 1557 | 0.060 |
Why?
|
| Heart Failure | 1 | 2012 | 1136 | 0.060 |
Why?
|
| Pulsatile Flow | 1 | 2002 | 49 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2012 | 1944 | 0.050 |
Why?
|
| Adolescent | 3 | 2017 | 8959 | 0.050 |
Why?
|
| Risk Factors | 1 | 2013 | 5251 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2013 | 3112 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2002 | 261 | 0.050 |
Why?
|
| HeLa Cells | 2 | 2012 | 498 | 0.050 |
Why?
|
| RNA Interference | 2 | 2012 | 369 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2013 | 7831 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2012 | 787 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 882 | 0.040 |
Why?
|
| Male | 6 | 2017 | 40654 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2017 | 1987 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2017 | 2836 | 0.040 |
Why?
|
| Adult | 4 | 2017 | 25522 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 1561 | 0.040 |
Why?
|
| Autografts | 1 | 2017 | 28 | 0.040 |
Why?
|
| Epigenesis, Genetic | 2 | 2013 | 482 | 0.040 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 110 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2017 | 88 | 0.040 |
Why?
|
| Anemia, Sickle Cell | 1 | 2017 | 131 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2017 | 443 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2015 | 185 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2015 | 260 | 0.030 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2012 | 12 | 0.030 |
Why?
|
| U937 Cells | 1 | 2012 | 32 | 0.030 |
Why?
|
| K562 Cells | 1 | 2012 | 44 | 0.030 |
Why?
|
| Pericytes | 1 | 2012 | 12 | 0.030 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2012 | 9 | 0.030 |
Why?
|
| Histone Demethylases | 1 | 2012 | 30 | 0.030 |
Why?
|
| Young Adult | 2 | 2017 | 5961 | 0.030 |
Why?
|
| Ribosomal Proteins | 1 | 2012 | 43 | 0.030 |
Why?
|
| eIF-2 Kinase | 1 | 2012 | 46 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 77 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 30 | 0.030 |
Why?
|
| Leptin | 1 | 2013 | 104 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2013 | 226 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2012 | 39 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2012 | 188 | 0.030 |
Why?
|
| Caspases | 1 | 2012 | 155 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 62 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2012 | 83 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2012 | 254 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 114 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2012 | 129 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 1604 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 265 | 0.030 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2011 | 5 | 0.030 |
Why?
|
| Adult Stem Cells | 1 | 2011 | 30 | 0.030 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2011 | 15 | 0.030 |
Why?
|
| Heterozygote | 1 | 2012 | 366 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2012 | 368 | 0.030 |
Why?
|
| Body Weight | 1 | 2013 | 451 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2013 | 516 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2011 | 158 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2012 | 459 | 0.020 |
Why?
|
| Aged | 2 | 2011 | 18161 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 279 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 827 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2010 | 55 | 0.020 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2010 | 41 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2013 | 359 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 2738 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 381 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 692 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 972 | 0.020 |
Why?
|
| Illinois | 1 | 2011 | 462 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 219 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 694 | 0.020 |
Why?
|
| Chromatin | 1 | 2012 | 384 | 0.020 |
Why?
|
| Remission Induction | 1 | 2011 | 722 | 0.020 |
Why?
|
| Haplotypes | 1 | 2011 | 639 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 617 | 0.020 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2009 | 12 | 0.020 |
Why?
|
| Middle Aged | 2 | 2011 | 24742 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 997 | 0.020 |
Why?
|
| Erythroid Precursor Cells | 1 | 2009 | 32 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2011 | 832 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2009 | 86 | 0.020 |
Why?
|
| Arginine | 1 | 2009 | 136 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 1106 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 238 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2012 | 599 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2011 | 1532 | 0.020 |
Why?
|
| Liver | 1 | 2013 | 1229 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1137 | 0.020 |
Why?
|
| Insulin | 1 | 2013 | 1148 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2010 | 731 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 636 | 0.020 |
Why?
|
| Incidence | 1 | 2011 | 1543 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 2389 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 1286 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2012 | 1200 | 0.020 |
Why?
|
| Pregnancy | 1 | 2013 | 2899 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2017 | 8466 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 1621 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 2354 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 1749 | 0.010 |
Why?
|